AM2250

Biodegradable implant for intravitreal use releasing the active ingredient over a period of 6 months. It is used for the treatment of age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion.

read more

Leuprorelin Implant

ready-to-use applicator with 3 month implant

read more

Goserelin Implant

ready-to-use applicator for 1 month or 3 month implant

read more